Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus Type 2 With Proteinuria”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Early research (Phase 1)Study completedNCT01464320
What this trial is testing

Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.

Who this might be right for
Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine
Abbott 16
Testing effectiveness (Phase 2)Study completedNCT03118739
What this trial is testing

Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria

Who this might be right for
HyperuricemiaAlbuminuriaType 2 Diabetes
AstraZeneca 60
Testing effectiveness (Phase 2)Study completedNCT01547897
What this trial is testing

NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria

Who this might be right for
Type 2 Diabetes MellitusAlbuminuria
TME Pharma AG 76
Post-approval studies (Phase 4)Study completedNCT00241085
What this trial is testing

Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus

Who this might be right for
PROTEINURIAHypertensionType 2 Diabetes
Novartis 392
Post-approval studies (Phase 4)Study completedNCT01588795
What this trial is testing

Renal Denervation in Diabetic Nephropathy

Who this might be right for
Diabetic NephropathyPersistent Proteinuria With Type II Diabetes
Assistance Publique - Hôpitaux de Paris 25
Post-approval studies (Phase 4)Ended earlyNCT03029351
What this trial is testing

GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes

Who this might be right for
Type2 DiabetesKidney Diseases
University at Buffalo 15
Post-approval studies (Phase 4)UnknownNCT00949351
What this trial is testing

Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With Nephropathy

Who this might be right for
Type 2 Diabetes With Nephropathy
Lerdsin General Hospital 80
Testing effectiveness (Phase 2)Study completedNCT01712061
What this trial is testing

Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy

Who this might be right for
Diabetic Nephropathy
Pfizer 226
Post-approval studies (Phase 4)Study completedNCT03983551
What this trial is testing

Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas

Who this might be right for
Type 2 Diabetes MellitusProteinuria
Changhua Christian Hospital 101
Not applicableEnded earlyNCT01101269
What this trial is testing

Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease

Who this might be right for
Type 2 Diabetes
University of Virginia 6
Testing effectiveness (Phase 2)Study completedNCT02010242
What this trial is testing

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

Who this might be right for
Type 2 Diabetes Mellitus With Diabetic Nephropathy
Calliditas Therapeutics AB 136
Post-approval studies (Phase 4)UnknownNCT01300273
What this trial is testing

Low Protein Diet Supplemented With Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in Type 2 Diabetic Nephropathy

Who this might be right for
Type 2 Diabetic Nephropathy
Shanghai Jiao Tong University School of Medicine 60
Testing effectiveness (Phase 2)Study completedNCT01109212
What this trial is testing

The Effects of Bindarit in Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Aziende Chimiche Riunite Angelini Francesco S.p.A 100
Testing effectiveness (Phase 2)Ended earlyNCT05268926
What this trial is testing

TreatIng Microalbuminuria Over 24 Weeks in Subjects With or Without Type 2 Diabetes or HYpertension

Who this might be right for
Albuminuria
University Medical Center Groningen 9
Testing effectiveness (Phase 2)Study completedNCT00920764
What this trial is testing

Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 92
Testing effectiveness (Phase 2)Study completedNCT01356849
What this trial is testing

Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) Inhibitor

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 149
Large-scale testing (Phase 3)Ended earlyNCT00462202
What this trial is testing

Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong

Who this might be right for
Diabetic Nephropathy
Keryx Biopharmaceuticals 200
Post-approval studies (Phase 4)Study completedNCT00550095
What this trial is testing

To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus

Who this might be right for
MicroalbuminuriaProteinuria
Novartis 509
Post-approval studies (Phase 4)Study completedNCT00234871
What this trial is testing

Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)

Who this might be right for
HypertensionDiabetesProteinuria
Abbott 357
Post-approval studies (Phase 4)Study completedNCT01028287
What this trial is testing

Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)

Who this might be right for
Diabetic NephropathyNephrotic Syndrome
Southeast Renal Research Institute 15
Load More Results